- Home
- ACRV vs LFT Comparison
ACRV vs LFT Comparison
Compare ACRV & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACRV | LFT |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.5M | 83.3M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACRV | LFT |
|---|---|---|
| Price | $2.49 | $1.41 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $14.67 | N/A |
| AVG Volume (30 Days) | ★ 602.2K | 197.6K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 11.35% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $21,708,246.00 |
| Revenue This Year | N/A | $124.75 |
| Revenue Next Year | $805.20 | N/A |
| P/E Ratio | ★ N/A | $14.98 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.05 | $1.41 |
| 52 Week High | $8.00 | $2.84 |
Technical Indicators
Market Signals| Indicator | ACRV | LFT |
|---|---|---|
| Relative Strength Index (RSI) | 59.87 | 37.36 |
| Support Level | $2.16 | $1.47 |
| Resistance Level | $2.55 | $1.56 |
| Average True Range (ATR) | 0.17 | 0.09 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 74.83 | 2.13 |
Price Performance
Historical ComparisonAbout ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.